1
Publications
43
Citations
1
H-Index
2024
Active since
Affiliations
G1 Therapeutics (United States)(Current)
Yu Quan is an author at G1 Therapeutics (United States) specializing in cell biology, cancer research, and immune cell therapy.
Publications per year
2024–2024
1
1
IGSF8 is an innate immune checkpoint and cancer immunotherapy target
Yulong Li, Xiangyang Wu, Caibin Sheng et al. · Cell · 2024 · 43 citations
Cancer Immunosurveillance, Innate Immune Checkpoint, Immunology +7
Rows per page
1–1 of 1